[PR Newswire] - ROCKVILLE, Md., March 1, 2013 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has received ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment